mRNA Technology Transfer Programme

MPP Logo

The mRNA technology transfer programme is a global initiative that aims to improve health and health security by establishing sustainable, locally owned mRNA manufacturing capabilities in and for low- and middle-income countries (LMICs).The programme is based around a technology transfer “hub” Afrigen, which is located in South Africa. They will provide the technology development, training and technology transfer, and 15-20 “spokes” in LMICs across the world, will receive training and technology from the hub and then produce and sell products commercially. Its core concept is empowerment.

Initially the programme will focus on mRNA vaccines against COVID-19. However, the programme is designed to encourage the development of other mRNA vaccines and therapeutics against important diseases that threaten LMICs, thereby ensuring the capacity built by the project is sustained and available to combat the next pandemic.


Latest news

News & Press Releases » Events

MPP’s Panel Discussion at the World Health Summit 2022

18 October 2022

News & Press Releases » Events

WHA 75 side event on the mRNA Technology Transfer Hub Programme

23 May 2022

News & Press Releases » Events

First Consultative Forum on the mRNA Vaccines Technology Transfer Hub

03 December 2021

Latest videos

MPP Logo

Subscribe to our Newsletter

Founded & funded by

Unitaid Logo

Other funders